Position in IMCR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,514,522
+$4,806,811 QoQ
Shares Held
299,670
+91.9% QoQ
Ownership
0.582%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 136 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $3,286,710,193 across 292 Biotechnology names. IMCR ranks #37 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,870,015 | $928,892,550 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
759,971 | $473,872,316 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
924,561 | $278,320,596 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,800,504 | $213,094,258 | |
| 5 | INCY |
Incyte Corp
|
1,605,980 | $182,053,892 | |
| 6 | ARGX |
Argenx SE
|
177,164 | $164,367,443 | |
| 7 | INSM |
INSMED Inc
|
826,431 | $88,114,072 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
381,366 | $71,422,223 |
All Filings in IMCR
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,514,522 | 299,670 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $4,707,711 | 156,143 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $5,183,348 | 149,333 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $4,568,715 | 125,756 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,867,239 | 123,239 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $4,203,497 | 141,675 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $4,037,812 | 136,875 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $3,633,244 | 116,712 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $4,084,321 | 120,517 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $2,342,925 | 36,045 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $2,479,674 | 36,295 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $1,436,903 | 27,686 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,437,481 | 23,974 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $299,309 | 6,054 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $328,152 | 5,750 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $720,482 | 15,349 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $589,199 | 15,792 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $668,833 | 22,369 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $765,914 | 22,369 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $937,018 | 25,277 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $745,503 | 19,091 | Shares | Defined | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||